Imaging Placebo Responses in the Brain

  • Luana Colloca
  • Fabrizio Benedetti


Over the past few years, there have been an increasing number of studies investigating placebo responses, with sophisticated techniques, such as positron emission tomography (PET), functional magnetic resonance imaging (fMRI), electroencephalography (EEG), magnetoencephalography (MEG) and recording from single neurons in awake patients. Most of our knowledge about the mechanisms that underlie the placebo effect comes from the field of pain and analgesia. However, the widespread interest in understanding the nature of the placebo effect within the neuroscience community has provided important insights into its neural mechanisms in other medical conditions, including Parkinson’s disease, depression, and drug addiction. Here, we review the literature that deals with placebo effects and brain imaging, and emphasize the contributions of macro- and micro-mapping studies to our understanding of the underlying brain processes. The knowledge of the placebo mechanisms across different systems and diseases makes it possible for us to identify the top-down processes that modulate the course of symptoms and diseases, as well as the specific action of drugs and the therapeutic response to their administration.


Positron Emission Tomography Irritable Bowel Syndrome Anterior Cingulate Cortex Placebo Effect Placebo Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



This work was supported by grants from Istituto San Paolo di Torino and Regione Piemonte.


  1. Alexander GE, DeLong MR, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357–381PubMedCrossRefGoogle Scholar
  2. Benedetti F (1996) The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia. Pain 64:535–543PubMedCrossRefGoogle Scholar
  3. Benedetti F (2002) How the doctor’ s words affect the patient’s brain. Eval Health Prof 25:369–386PubMedCrossRefGoogle Scholar
  4. Benedetti F (2008) Mechanisms of placebo and placebo-related effects across diseases and treatments. Annu Rev Pharmacol Toxicol 48:33–60PubMedCrossRefGoogle Scholar
  5. Benedetti F, Amanzio M, Casadio C, Oliaro A, Maggi G (1997) Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide. Pain 71:135–140PubMedCrossRefGoogle Scholar
  6. Benedetti F, Colloca L, Torre E, Lanotte M, Melcarne A, Pesare M, Bergamasco B, Lopiano L (2004a) Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nature Neurosci 7:587–588PubMedCrossRefGoogle Scholar
  7. Benedetti F, Colloca L, Lanotte M, Melcarne A, Torre E, Bergamasco B, Lopiano L (2004b) Autonomic and emotional responses to open-hidden stimulation of subthalamic region. Brain Res Bull 63:203–211PubMedCrossRefGoogle Scholar
  8. Benedetti F, Mayberg HS, Wager TD, Stohler CS, Zubieta JK (2005) Neurobiological mechanisms of the placebo effect. J Neurosci 25(45):10390–10402PubMedCrossRefGoogle Scholar
  9. Benedetti B, Arduino C, Costa S, Vighetti S, Tarenzi L, Rainero I, Asteggiano G (2006) Loss of expectation-related mechanisms in Alzheimer’s disease makes analgesic therapies less effective. Pain 121(1–2):133–144PubMedCrossRefGoogle Scholar
  10. Bingel U, Lorenz J, Schoell E, Weiller C, Büchel C (2006) Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain 120(1–2):8–15PubMedCrossRefGoogle Scholar
  11. Colloca L, Benedetti F (2005) Placebos and painkillers: is mind as really as matter? Nature Rev Neurosci 6(7):545–552CrossRefGoogle Scholar
  12. Colloca L, Lopiano L, Lanotte M, Benedetti F (2004) Overt versus covert treatment for pain, anxiety, and Parkinson’s disease. Lancet Neurol 3(11):679–684PubMedCrossRefGoogle Scholar
  13. Colloca L, Lui F, Duzzi D, Nocetti L, Anchisi D, Benuzzi F, Baraldi P, Benedetti F, Porro CA (2008) Brain correlates of conditioned placebo analgesia. Abstract presented at Organization for Human Brain Mapping (OHBM) Congress, Melbourne, AustraliaGoogle Scholar
  14. de la Fuente-Fernandez R, Ruth TJ, Sossi V, Schulzer M, Calne DB, Stoessl AJ (2001) Expectation and dopamine release: mechanism of the placebo effect in Parkinson’s disease. Science 293:1164–1166PubMedCrossRefGoogle Scholar
  15. de la Fuente-Fernandez R, Phillips AG, Zamburlini M, Sossi V, Calne DB, Ruth TJ, Stoessl AJ (2002) Dopamine release in human ventral striatum and expectation of reward. Behav Brain Res 136:359–363PubMedCrossRefGoogle Scholar
  16. Fields HL (2004) State-dependent opioid control of pain. Nat Rev Neurosci 5(7):565–575PubMedCrossRefGoogle Scholar
  17. Fields HL, Basbaum AI (1994) Central nervous system mechanism of pain modulation. In: Wall PD, Melzack R (eds) Textbook of pain. Churchill Livingstone, New York, pp 243–257Google Scholar
  18. Fields HL, Levine JD (1984) Placebo analgesia – a role for endorphins. Trends Neurosci 7:271–273CrossRefGoogle Scholar
  19. Fields HL, Price DD (1997) Towards a neurobiology of placebo analgesia. In: Harrington A (ed) The placebo effect: an interdisciplinary exploration. Harvard University Press, Cambridge, pp 93–116Google Scholar
  20. Garcia-Larrea L, Frot M, Valeriani M (2003) Brain generators of laser-evoked potentials: from dipoles to functional significance. Neurophysiol Clin 33(6):279–292PubMedCrossRefGoogle Scholar
  21. Goffaux P, Redmond WJ, Rainville P, Marchand S (2007) Descending analgesia – when the spine echoes what the brain expects. Pain 130(1–2):137–143PubMedCrossRefGoogle Scholar
  22. Gospic K, Gunnarsson T, Fransson P, Ingvar M, Lindefors N, Petrovic P (2008) Emotional perception modulated by an opioid and cholecystokinin agonist. Psychopharmacology 197(2):295–307Google Scholar
  23. Hoffma GA, Harrington A, Fields HL (2005) Pain and the placebo: what we have learned. Perspect Biol Med 48(2):248–265CrossRefGoogle Scholar
  24. Kaufmann H, Bhattacharya KF, Voustianiouk A, Gracies JM (2002) Stimulation of the subthalamic nucleus increases heart rate in patients with Parkinson disease. Neurology 59:1657–1658PubMedGoogle Scholar
  25. Keltner JR, Furst A, Fan C, Redfern R, Inglis B, Fields HL (2006) Isolating the modulatory effect of expectation on pain transmission: a functional magnetic resonance imaging study. J Neurosci 26(16):4437–4443PubMedCrossRefGoogle Scholar
  26. Kong J, Gollub RL, Rosman IS, Webb JM, Vangel MG, Kirsch I, Kaptchuk TJ (2006) Brain activity with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. J Neurosci 26(2):381–388PubMedCrossRefGoogle Scholar
  27. Koyama T, McHaffie JG, Laurienti PJ, Coghill RC (2005) The subjective experience of pain: where expectations became reality. Proc Natl Acad Sci USA 102(36):12950–12955PubMedCrossRefGoogle Scholar
  28. Lanotte M, Lopiano L, Torre E, Bergamasco B, Colloca L, Benedetti F (2005) Expectaction enhances autonomic responses to stimulation of the human subthalamic limbic region. Brain Behav Immun 19(6):500–509PubMedCrossRefGoogle Scholar
  29. Leuchter AF, Cook IA, Witte EA, Morgan M, Abrams M (2002) Changes in brain function of depressed subjects during treatment with placebo. Am J Psychiatry 159:122–129PubMedCrossRefGoogle Scholar
  30. Leuchter AF, Morgan M, Cook IA, Dunkin J, Abrams M, Witte EA (2004) Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression. Psychopharmacology 177(1–2):15–22PubMedCrossRefGoogle Scholar
  31. Levine JD, Gordon NC, Fields HL (1978) The mechanism of placebo analgesia. Lancet 2(8091):
654–657Google Scholar
  32. Levy R, Dostrovsky JO, Lang AE, Sime E, Hutchison WD, Lozano AM (2001) Effects of apomorphine on subthalamic nucleus and globus pallidus internus neurons in patients with Parkinson’s disease. J Neurophysiol 86(1):249–260PubMedGoogle Scholar
  33. Lieberman MD, Jarcho JM, Berman S, Naliboff BD, Suyenobu BY, Mandelkern M, Mayer EA (2004) The neural correlates of placebo effects: a disruption account. Neuroimage 22:447–455PubMedCrossRefGoogle Scholar
  34. Lorenz J, Hauck M, Paur RC, Nakamura Y, Zimmermann R, Bromm B, Engel AK (2005) Cortical correlates of false expectations during pain intensity judgments – a possible manifestation of placebo/nocebo cognitions. Brain Behav Immun 19:283–295PubMedCrossRefGoogle Scholar
  35. Lozano AM, Lang AE, Levy R, Hutchison W, Dostrovsky J (2000) Neuronal recordings in Parkinson’s disease patients with dyskinesias induced by apomorphine. Ann Neurol 47:S141–S146CrossRefGoogle Scholar
  36. Mayberg HS, Silva JA, Brannan SK, Tekell JL, Mahurin RK, McGinnis S, Jerabek PA (2002) The functional neuroanatomy of the placebo effect. Am J Psychiatry 159(5):728–737PubMedCrossRefGoogle Scholar
  37. Parent A, Hazrati LN (1995) Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Rev 20:128–154PubMedCrossRefGoogle Scholar
  38. Petrovic P, Kalso E, Petersson KM, Ingvar M (2002) Placebo and opioid analgesia – imaging a shared neuronal network. Science 295(5560):1737–1740PubMedCrossRefGoogle Scholar
  39. Petrovic P, Dietrich T, Fransson P, Andersson J, Carlsson K, Ingvar M (2005) Placebo in emotional processing – induced expectations of anxiety relief activate a generalized modulatory network. Neuron 46:957–969PubMedCrossRefGoogle Scholar
  40. Price DD (1999) Placebo analgesia. In: Price DD (ed) Psychological mechanisms of pain and analgesia, progress in pain research and management, vol 15. IASP Press, Seattle, pp 155–181Google Scholar
  41. Price DD, Craggs J, Nicholas Verne G, Perlstein WM, Robinson ME (2007) Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain 127(1–2):63–72PubMedCrossRefGoogle Scholar
  42. Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK (2007) Individual differences in reward responding explain placebo-induced expectations and effects. Neuron 55:325–336PubMedCrossRefGoogle Scholar
  43. Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK (2008) Placebo and nocebo are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry 65(2):220–2321PubMedCrossRefGoogle Scholar
  44. Strafella AP, Ko JH, Monchi O (2006) Therapeutic application of transcranial magnetic stimulation in Parkinson’s disease: the contribution of expectation. Neuroimage 31(4):1666–1672PubMedCrossRefGoogle Scholar
  45. Thornton JM, Aziz T, Schlugman D, Paterson DJ (2002) Electrical stimulation of the midbrain increases heart rate and arterial blood pressure in awake humans. J Physiol 539:615–621PubMedCrossRefGoogle Scholar
  46. Volkow ND, Wang GJ, Ma Y, Fowler JS, Zhu W, Maynard L, Telang F, Vaska P, Ding YS, Wong C, Swanson JM (2003) Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci 23(36):11461–11468PubMedGoogle Scholar
  47. Volkow ND, Wang GJ, Ma Y, Fowler JS, Wong C, Jayne M, Telang F, Swanson JM (2006) Effects of expectation on the brain metabolic responses to methylphenidate and to its placebo in non-drug abusing subjects. Neuroimage 32:1782–1792PubMedCrossRefGoogle Scholar
  48. Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ, Kosslyn SM, Rose RM, Cohen JD (2004) Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 303(5661):1162–1167PubMedCrossRefGoogle Scholar
  49. Wager TD, Matre D, Casey KL (2006) Placebo effects in laser-evoked pain potentials. Brain Behav Immun 20(3):219–230PubMedCrossRefGoogle Scholar
  50. Wager TD, Scott DJ, Zubieta JK (2007) Placebo effects on human μ-opioid activity during pain. PNAS 104(26):11056–11061PubMedCrossRefGoogle Scholar
  51. Watson A, Deredy W, Vogt BA, Jones AK (2007) Placebo analgesia is not due to compliance or habituation: EEG and behavioural evidence. Neuroreport 28(8):771–775CrossRefGoogle Scholar
  52. Willoch F, Tolle TR, Wester HJ, Munz F, Petzold A, Schwaiger M, Conrad B, Bartenstein P (1999) Central pain after pontine infarction is associated with changes in opioid receptor binding: a PET study with 11 C-diprenorphine. AJNR Am J Neuroradiol 20(4):686–690PubMedGoogle Scholar
  53. Willoch F, Schindler F, Wester HJ, Empl M, Straube A, Schwaiger M, Conrad B, Tolle TR (2004) Central poststroke pain and reduced opioid receptor binding within pain processing circuitries: a [11C]diprenorphine PET study. Pain 108(3):213–220PubMedCrossRefGoogle Scholar
  54. Zubieta JK, Bueller JA, Jackson LR, Scott DJ, Xu Y, Koeppe RA, Nichols TE, Stohler C (2005) Placebo effects mediated by endogenous opioid activity on μ-opioid receptors. J Neurosci 25(34):7754–7762PubMedCrossRefGoogle Scholar
  55. Zubieta JK, Yau WY, Scott DJ, Stolher CS (2006) Belief or need? Accounting for individual variations in the neurochemistry of the placebo effect. Brain Behav Immun 20:15–26PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Dipartimento di NeuroscienzeUniversità di TorinoTorinoItaly

Personalised recommendations